Published in Neurodegeneration on June 01, 1995
Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J (1969) 3.37
Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J (1970) 2.91
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev (2012) 2.49
Helicobacter pylori infection in children: potential clues to pathogenesis. J Pediatr Gastroenterol Nutr (1993) 2.25
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry (2008) 2.24
Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet (1971) 2.22
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev (2007) 2.20
Endometriosis and ovulatory disorder: reduced fertilisation in vitro compared with tubal and unexplained infertility. Lancet (1985) 2.00
The liver to abdominal area ratio (LAAR): a novel imaging score for prognostication in cirrhosis. Aliment Pharmacol Ther (2013) 1.98
Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med (1992) 1.90
Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol (2001) 1.87
Immunologic function and survival in hemodialysis patients. Kidney Int (1998) 1.82
Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol (1998) 1.80
The specificity of surface membrane immunofluorescence in human malignant melanoma. Int J Cancer (1972) 1.75
Nucleic acid splicing events occur frequently during macronuclear development in the protozoan Oxytricha nova and involve the elimination of unique DNA. Genes Dev (1987) 1.72
Circulating immune complexes in schistosomiasis due to Schistosoma mansoni. Br Med J (1975) 1.51
Chronic expanding hematoma of the thorax. AJR Am J Roentgenol (2003) 1.50
Presence of anti-pituitary hormone antibodies in patients with empty sella syndrome and pituitary tumours. Clin Endocrinol (Oxf) (1993) 1.49
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord (2003) 1.41
Increase in plasma progestagen concentrations in the mare after foetal injection with CRH, ACTH or betamethasone in late gestation. Equine Vet J (1992) 1.39
Interactions between sulphonamides and thyroxine. Hum Exp Toxicol (1991) 1.38
The estimation of serum fructosamine: an alternative measurement to glycated haemoglobin. Ann Clin Biochem (1985) 1.35
Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem (1992) 1.18
Three-dimensional reconstruction of ventricular septal defects: validation studies and in vivo feasibility. J Am Coll Cardiol (1994) 1.17
Encephalopathy associated with ifosphamide/mesna therapy. Lancet (1985) 1.17
Epstein-Barr virus shedding by astronauts during space flight. Brain Behav Immun (2005) 1.16
Herpes simplex type 2 encephalitis concurrent with known cerebral metastases. Acta Neuropathol (1979) 1.13
Target role of Langerhans cells in mycosis fungoides: transmission and immuno-electron microscopic studies. J Cutan Pathol (1979) 1.10
Toxicity of wheat gliadin fractions in coeliac disease. Lancet (1973) 1.07
Norethisterone treatment to control timing of the IVF cycle. Hum Reprod (1986) 1.06
Dyadic relationship conflict, gender, and mortality in urban hemodialysis patients. J Am Soc Nephrol (2000) 1.03
Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine (2001) 1.02
Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol (1992) 1.02
Submucosal "dissection" in collagenous colitis. Gut (2004) 1.01
Human botulism. Br J Hosp Med (1990) 1.01
Renin levels in nephroblastoma (Wilms' tumour). Report of a renin secreting tumour. Arch Dis Child (1970) 1.01
Central nervous system sarcoidosis. Q J Med (1985) 1.00
Immunoregulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice. Magnes Res (1996) 0.99
Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition. Circ Res (1994) 0.98
Microvascular assessment of burn depth conversion during varying resuscitation conditions. J Burn Care Rehabil (2001) 0.97
The diagnostic value of glycated haemoglobin levels in post-mortem blood. Ann Clin Biochem (1985) 0.97
HIV-associated immune-mediated renal disease. Kidney Int (1993) 0.97
Enzyme changes in human small bowel mucosa during culture in vitro. Gut (1974) 0.97
The use of activated glutaraldehyde as a cold sterilizing agent for urological instruments. J Urol (1966) 0.96
The sex ratio in familial persistent stuttering. Am J Hum Genet (1999) 0.96
Diagnostic issues in a family with late onset type 2 neurofibromatosis. J Med Genet (1995) 0.96
Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol (1985) 0.95
Stereoselective reduction of pyruvate by sodium borohydride catalyzed by pyruvate kinase. Biochim Biophys Acta (1973) 0.95
Serum fructosamine and glycated haemoglobin measurements in diabetic control. Arch Dis Child (1986) 0.94
Immunological associations of the halo naevus with cutaneous malignant melanoma. Br J Dermatol (1973) 0.94
Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition. Mol Cell Biochem (1994) 0.94
Evaluation of a new mineral and trace metal supplement for use with synthetic diets. Arch Dis Child (1977) 0.94
A system of immunofluorescence in the study of tumour cells. Rev Eur Etud Clin Biol (1970) 0.93
Patients' health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. J Neurol Sci (2001) 0.93
Unilateral megalencephaly, cerebral cortical dysplasia, neuronal hypertrophy, and heterotopia: cytomorphometric, fluorometric cytochemical, and biochemical analyses. Acta Neuropathol (1979) 0.93
Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes (1990) 0.92
Motor neurone disease in the Lothian Region of Scotland 1961-81. J Epidemiol Community Health (1986) 0.92
Possible explanation for loss of detectable antibody in patients with disseminated malignant melanoma. Nature (1971) 0.92
The 2003 Carl A Moyer Award: real-time metabolic monitors, ischemia-reperfusion, titration endpoints, and ultraprecise burn resuscitation. J Burn Care Rehabil (2004) 0.91
Separation of two distinct tumor-associated antibodies in the serum of melanoma patients. J Natl Cancer Inst (1972) 0.91
Focal lymphocytic thyroiditis in Southampton. J Pathol (1984) 0.91
Visual evoked potential and contrast sensitivity function in diabetic retinopathy. Br Med J (Clin Res Ed) (1985) 0.91
Multislab three-dimensional T2-weighted fast spin-echo imaging of the hippocampus: sequence optimization. J Magn Reson Imaging (1995) 0.90
Update on topical cyclosporin A. Background, immunology, and pharmacology. Cornea (1990) 0.90
Ia antigens on indeterminate cells of the epidermis: immunoelectronmicroscopic studies of surface antigens. Br J Dermatol (1979) 0.90
Magnesium-deficiency-enhanced post-ischemic myocardial injury is reduced by substance P receptor blockade. J Mol Cell Cardiol (1997) 0.89
Detection of carbamyl phosphate synthetase 1 deficiency using duodenal biopsy samples. Arch Dis Child (1980) 0.89
Myoglobinuria due to heroin abuse. J R Soc Med (1985) 0.88
Characterization of the fertilization antigen 1 for the development of a contraceptive vaccine. Proc Natl Acad Sci U S A (1986) 0.88
Effect of renal replacement therapy on cellular cytokine production in patients with renal disease. Kidney Int (1990) 0.88
Immune complex arthritis in a patient with Schistosoma mansoni infection. Arthritis Rheum (1986) 0.88
Immune complexes in human melanoma: a consequence of deranged immune regulation. Scand J Immunol (1976) 0.88
Operation for recurrent ventricular tachycardia. Predictors of short- and long-term efficacy. J Thorac Cardiovasc Surg (1994) 0.87
Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis). J Neurol Sci (1995) 0.87
Evidence for DNA damage in amyotrophic lateral sclerosis. Muscle Nerve (1996) 0.87
Patients' health-related quality-of-life and health state values for motor neurone disease/amyotrophic lateral sclerosis. Qual Life Res (2003) 0.87
Volatile constituents of the Argentine ant, Iridomyrmex humilis. J Insect Physiol (1974) 0.86
Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency--modulation by nitric oxide synthase inhibition. Mol Cell Biochem (1997) 0.86
3-Hydroxy- and 3-keto-3-phenylpropionic acids: novel metabolites of benzoic acid in horse urine. Biochem Pharmacol (1982) 0.86
Heavy metals and trace elements in amyotrophic lateral sclerosis. Neurol Clin (1987) 0.85
Excretion of sodium 2-mercaptoethanesulphonate (MESNA) in the urine of volunteers after oral dosing. Eur J Cancer Clin Oncol (1985) 0.85
Dissection of the intracranial internal carotid artery producing isolated oculomotor nerve palsy with sparing of pupil. Acta Neurol Scand (2002) 0.84
Response of interleukin-1beta in the magnocellular system to salt-loading. J Neuroendocrinol (2006) 0.84
Screening and confirmatory analysis of beta-agonists, beta-antagonists and their metabolites in horse urine by capillary gas chromatography-mass spectrometry. J Chromatogr (1991) 0.84
Electrospray collision-induced dissociation of testosterone and testosterone hydroxy analogs. J Mass Spectrom (1999) 0.84
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev (2000) 0.84
Inverse correlation between age related abnormalities of T-cell immunity and circulating thymosin alpha 1 levels in haemophilia A. Br J Haematol (1984) 0.84
Decreased plasma half-life of cyclophosphamide during repeated high-dose administration. Cancer Chemother Pharmacol (1983) 0.84
Visual function in multiple sclerosis. Doc Ophthalmol (1989) 0.83
Quality of life in motor neurone disease--towards a more practical assessment tool? J Neurol Neurosurg Psychiatry (2003) 0.83
VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death. Brain Res (1999) 0.83
Urinary albumin measurement by immunoturbidimetry. Ann Clin Biochem (1987) 0.83
Plasma progestagens in the mare, fetus and newborn foal. J Reprod Fertil Suppl (1991) 0.82
Cytokines, neuropeptides, and reperfusion injury during magnesium deficiency. Ann N Y Acad Sci (1994) 0.82
Gas chromatography-mass spectrometry/mass spectrometry analysis to determine natural and post-administration levels of oestrogens in bovine serum and urine. Anal Chim Acta (2006) 0.82
Tumor-associated antigens in human malignant melanoma. Yale J Biol Med (1973) 0.82
Interferons and cerebral palsy. J Pediatr (1999) 0.82